SHC: financial statements from SEC — TradeAlmanac

SHC

Sotera Health Company: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Dec 2025	31 Dec 2024
Revenue	1.16B	1.10B
Cost of revenue	518M	498M
Gross profit	646M	602M
Selling, general and administrative	253M	243M
Operating expenses	—	305M
Operating income	—	298M
Pre-tax income	148M	114M
Income tax	70M	69M
Net income	78M	44M
Earnings per share	0.27	0.16
Earnings per share, diluted	0.27	0.16
Weighted average shares	284M	283M
Weighted average shares, diluted	286M	285M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	314M	345M	299M	332M	304M	277M	308M	248M
Receivables	137M	139M	142M

Cash flow

Metric	31 Dec 2025	31 Dec 2024
Operating cash flow	287M	224M
Depreciation and amortisation	95M	84M
Share-based compensation	31M	37M
Capital expenditure	138M	179M
Investing cash flow	−135M	−179M
Financing cash flow	−101M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator